Cascade-Amplifying Immunophototherapy Nanoplatform Integrating Cocktail Drug Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Photodynamic therapy (PDT) shows promise for melanoma but is hindered by tumor hypoxia, high glutathione, and melanin's properties.
• Melanin's antioxidant and light-absorbing characteristics significantly limit PDT efficacy in melanoma treatment.

Purpose of the Study:

• To develop a cascade-amplified biomimetic nanoplatform (Cyan-Cu) for enhanced melanoma therapy.
• To overcome limitations of PDT in melanoma by addressing tumor hypoxia and melanin interference.

Main Methods:

• Assembled cyanobacteria (Cyan) with DSPE-PEG-NH2-decorated copper (II) phthalocyanine (CuPc) to create the Cyan-Cu nanoplatform.
• Utilized 635 nm laser irradiation to activate Cyan-Cu for simultaneous reactive oxygen species and heat generation (immunophototherapy).
• Investigated Cyan's role in suppressing tyrosinase activity to reduce melanin synthesis and potentiate PDT and cuproptosis.

Main Results:

• Cyan-Cu generated reactive oxygen species and heat, functioning as a cocktail drug delivery system.
• Cyan effectively suppressed tyrosinase activity, reducing melanin and enhancing PDT and cuproptosis.
• In vivo studies showed reduced melanin, suppressed bilateral tumor growth, and dual-mode immune activation.

Conclusions:

• The Cyan-Cu platform significantly enhances melanoma therapy by overcoming melanin-related PDT limitations.
• Cyan plays a crucial role in antimelanoma therapy by modulating melanin synthesis and potentiating treatment effects.
• The Cyan-Cu platform demonstrates therapeutic potential as a multimodal synergistic strategy for melanoma treatment.